Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Sumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
International Journal of Hematology
|
July 9, 2017
Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan
Akio Saito, Atsushi Isoda, Masaru Kojima, et al.
Oncotarget
|
November 10, 2018
Clinical impact of serum soluble SLAMF7 in multiple myeloma
Mariko Ishibashi, Saori Soeda, Makoto Sasaki, et al.
Annals of Hematology
|
July 1, 2016
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era
Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, et al.
Molecular Cancer Research : MCR
|
January 25, 2020
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
Mariko Ishibashi, Risa Takahashi, Asako Tsubota, et al.
International Journal of Hematology
|
November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
Tsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
Blood
|
March 1, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
Yasunori Kogure, Hiroshi Handa, Yuta Ito, et al.
Annals of Hematology
|
September 11, 2023
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
Yuichi Horigome, Masaki Iino, Yoriko Harazaki, et al.
International Journal of Hematology
|
March 29, 2024
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021)
Hirohiko Shibayama, Mitsuhiro Itagaki, Hiroshi Handa, et al.
Leukemia & Lymphoma
|
November 1, 2012
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Yasunori Ueda, Chisato Mizutani, Yasuhito Nannya, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Sumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
International Journal of Hematology
|
July 9, 2017
Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan
Akio Saito, Atsushi Isoda, Masaru Kojima, et al.
Oncotarget
|
November 10, 2018
Clinical impact of serum soluble SLAMF7 in multiple myeloma
Mariko Ishibashi, Saori Soeda, Makoto Sasaki, et al.
Annals of Hematology
|
July 1, 2016
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era
Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, et al.
Molecular Cancer Research : MCR
|
January 25, 2020
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
Mariko Ishibashi, Risa Takahashi, Asako Tsubota, et al.
International Journal of Hematology
|
November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
Tsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
Blood
|
March 1, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
Yasunori Kogure, Hiroshi Handa, Yuta Ito, et al.
Annals of Hematology
|
September 11, 2023
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
Yuichi Horigome, Masaki Iino, Yoriko Harazaki, et al.
International Journal of Hematology
|
March 29, 2024
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021)
Hirohiko Shibayama, Mitsuhiro Itagaki, Hiroshi Handa, et al.
Leukemia & Lymphoma
|
November 1, 2012
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Yasunori Ueda, Chisato Mizutani, Yasuhito Nannya, et al.
Page
of 7